Home > Boards > US Listed > Biotechs > Clovis Oncology, Inc. (CLVS)

Chart looks good

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
PennyStock Alert Member Profile
 
Followed By 507
Posts 41,259
Boards Moderated 5
Alias Born 04/26/12
160x600 placeholder
Clovis Oncology Retires Remaining 2021 Notes and Raises Additional Capital through its ATM Equity Offering Program Business Wire - 9/20/2021 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/3/2021 4:17:04 PM
Clovis Oncology Announces Availability of and Reimbursement for Rubraca® (rucaparib) Tablets for Women with Relapsed Ovarian Cancer in Switzerland Business Wire - 8/24/2021 2:00:00 AM
Clovis Oncology gibt die Verfügbarkeit und Erstattung von Rubraca® (Rucaparib) Tabletten für Frauen mit rezidiviertem Eierstockkrebs in der Schweiz bekannt Business Wire - 8/24/2021 2:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/16/2021 4:34:32 PM
Clovis Oncology Announces Renewal of At-The-Market Equity Offering Program Business Wire - 8/16/2021 4:21:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/4/2021 1:02:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/4/2021 8:06:35 AM
Clovis Oncology EPS misses by $0.04, misses on revenue Seeking Alpha - 8/4/2021 8:04:32 AM
Clovis Oncology Announces Second Quarter 2021 Operating Results Business Wire - 8/4/2021 8:00:00 AM
Clovis Oncology to Announce Second Quarter 2021 Financial Results and Host Webcast Conference Call on August 4 Business Wire - 7/21/2021 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/13/2021 4:26:25 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/13/2021 8:10:52 AM
Clovis Oncology adds Ronit Simantov to board of directors Seeking Alpha - 7/12/2021 4:15:39 PM
Clovis Oncology Appoints Dr. Ronit Simantov to its Board of Directors Business Wire - 7/12/2021 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/6/2021 4:16:38 PM
Initial Clinical Experience of FAP-2286 in Independent Named Patient Use Published in The Journal of Nuclear Medicine Business Wire - 6/28/2021 7:00:00 AM
Senseonics and Clovis Oncology gain ahead of inclusion in Russell Indexes Seeking Alpha - 6/25/2021 2:07:36 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 6/23/2021 4:31:45 PM
Clovis starts enrollment of phase 1/2 trial for candidate to treat tumors Seeking Alpha - 6/23/2021 7:39:39 AM
Clovis Oncology Announces LuMIERE Clinical Trial Evaluating Novel Peptide-Targeted Radionuclide Therapy FAP-2286 Now Open for... Business Wire - 6/23/2021 7:00:00 AM
Clovis Oncology gain attributed to a policy bulletin issued by Aetna Seeking Alpha - 6/14/2021 10:14:32 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/10/2021 4:39:54 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/10/2021 4:36:15 PM
Clovis Oncology Announces Partial Adjournment of Annual Meeting of Stockholders Business Wire - 6/10/2021 4:30:00 PM
PennyStock Alert   Friday, 01/18/19 08:43:51 PM
Re: None
Post # of 686 
Chart looks good



:)

All my posts are my opinion only. Please do your due diligence on all your investments.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences